Skip to main content

Date: Aug. 22, 2023
Author: Andrew Amari, JD, APTA health policy and payment specialist

If you've been paying even just a little attention to APTA's regulatory advocacy efforts, you may have noticed a few new(ish) resources, seen calls to action using APTA's regulatory commenting tool, or heard pleas from the health policy and payment team to join us in commenting on a proposed rule.

If you're wondering what all the hubbub is about, or why APTA shifted its approach toward member-authored comment letters, it's because federal agencies have changed how they think about the comments they receive. It's in the profession's best interest to respond to those changes. As we ramp up our efforts to respond to the critically important 2024 Physician Fee Schedule proposed rule, here's an overview of why it's more important than ever to get involved in regulatory advocacy.

Log in or create a free account to keep reading.


Join APTA to get unlimited access to content.


You Might Also Like...

Article

CMS Finalizes Fee Schedule Pay Bump for the First Time in 5 Years

Nov 18, 2025

The U.S. Centers for Medicare & Medicaid Services finalized a 3.26% increase to the conversion factor in the final Medicare Part B Physician Fee Schedule

News

APTA Advocacy Leads to Noridian Updated Guidance on Plan of Care Signature

Oct 14, 2025

On Sept. 10, the Medicare Administrative Contractor Noridian Healthcare Solutions amended its existing guidance on the regulations governing certification

News

Shutdown FAQs: Impact on Federal Payors, Health Care Practices, and Telehealth

Sep 25, 2025

Note: This article has been updated to reflect APTA’s latest analysis of the federal government’s official shutdown and subsequent related guidance as